<SEC-DOCUMENT>0001193125-18-271302.txt : 20180912
<SEC-HEADER>0001193125-18-271302.hdr.sgml : 20180912
<ACCEPTANCE-DATETIME>20180912071705
ACCESSION NUMBER:		0001193125-18-271302
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180912
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180912
DATE AS OF CHANGE:		20180912

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTREXON CORP
		CENTRAL INDEX KEY:			0001356090
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36042
		FILM NUMBER:		181065933

	BUSINESS ADDRESS:	
		STREET 1:		1750 KRAFT DRIVE
		STREET 2:		SUITE 1400
		CITY:			BLACKSBURG
		STATE:			VA
		ZIP:			24060
		BUSINESS PHONE:		301-556-9809

	MAIL ADDRESS:	
		STREET 1:		1750 KRAFT DRIVE
		STREET 2:		SUITE 1400
		CITY:			BLACKSBURG
		STATE:			VA
		ZIP:			24060
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d622770d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): September&nbsp;12, 2018 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>INTREXON CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><B>Virginia</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-36042</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><FONT STYLE="white-space:nowrap">26-0084895</FONT></B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State or Other Jurisdiction<BR>of Incorporation)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Commission<BR>File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer<BR>Identification No.)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>20374 Seneca Meadows Parkway, Germantown, Maryland 20876 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(301) <FONT STYLE="white-space:nowrap">556-9900</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s Telephone Number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former Name or
Former Address, if change since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-12</FONT> under the Exchange Act
(17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to <FONT
STYLE="white-space:nowrap">Rule&nbsp;14d-2(b)&nbsp;under</FONT> the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to <FONT
STYLE="white-space:nowrap">Rule&nbsp;13e-4(c)&nbsp;under</FONT> the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 <FONT
STYLE="white-space:nowrap">or&nbsp;Rule&nbsp;12b-2&nbsp;of&nbsp;the</FONT> Securities Exchange Act of 1934. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer
of Listing. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;12, 2018, Intrexon Corporation (the &#147;Company&#148;) provided written notice to the New York Stock
Exchange (the &#147;NYSE&#148;) of its intention to voluntarily transfer the listing of its common stock, no par value, to the&nbsp;Nasdaq&nbsp;Global Select Market (&#147;Nasdaq&#148;).&nbsp;On September&nbsp;11, 2018, the Company&#146;s Board of
Directors approved the transfer of the listing to Nasdaq, and the Company&#146;s common stock has been approved for listing by Nasdaq. The Company expects to cease trading on the NYSE at market close on September&nbsp;24, 2018 and to commence
trading on&nbsp;Nasdaq&nbsp;on September&nbsp;25, 2018 under the Company&#146;s current stock symbol &#147;XON&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7.01 Regulation FD
Disclosure. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;12, 2018, the Company issued a press release announcing the transfer of the listing of its common stock
to Nasdaq. A copy of the Company&#146;s press release announcing the transfer of the listing is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)
Exhibits. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d622770dex991.htm">Press release dated September&nbsp;12, 2018. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Intrexon Corporation</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Donald P. Lehr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Donald P. Lehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Legal Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:&nbsp;September&nbsp;12, 2018 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d622770dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g622770g0912085230824.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Intrexon Announces Transfer of Stock Listing to Nasdaq </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Ticker symbol to remain &#147;XON&#148; </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GERMANTOWN, MD, September</B><B></B><B>&nbsp;12, 2018</B> &#150; <U>Intrexon Corporation</U> (NYSE: XON), a leader in the engineering and industrialization
of biology to improve the quality of life and health of the planet, today announced that it is transferring its stock exchange listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market (Nasdaq). Intrexon will retain the
&#147;XON&#148; ticker with trading on the Nasdaq exchange expected to begin on September&nbsp;25, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Following a careful review, we have
concluded that our shareholders will be served better by our listing on Nasdaq, with its superior technology, trading liquidity, visibility and opportunities for investor outreach,&#148; said Randal J. Kirk, Chairman and Chief Executive Officer of
Intrexon. &#147;We look forward to our partnership with Nasdaq.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Intrexon has been driving innovation in the biotechnology industry with its
development and engineering in synthetic biology,&#148; said Nelson Griggs, President of Nasdaq Stock Exchange. &#147;As home to the leading biotechnology companies, we are excited to be their exchange partner as the company strives to help address
some of the world&#146;s most pressing challenges.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Intrexon Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> to create
biologically-based products that improve the quality of life and the health of the planet. Intrexon&#146;s integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological
systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, and we invite you to discover more at
<U>www.dna.com</U> or follow us on Twitter at <U>@Intrexon</U>, on <U>Facebook</U>, and <U>LinkedIn</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trademarks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks
of their respective owners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and
projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking
statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For more information regarding Intrexon
Corporation, contact: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven Harasym</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor Relations</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: +1 (214) <FONT
STYLE="white-space:nowrap">721-0607</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>investors@dna.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Contact:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marie Rossi, PhD</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Communications</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: +1 (301) <FONT
STYLE="white-space:nowrap">556-9850</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>publicrelations@dna.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g622770g0912085230824.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g622770g0912085230824.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  K ,(# 2(  A$! Q$!_\0
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<R3WH \/HKUO_ (0SP_\ ] \?]_G_ /BJ* /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
